ZBTB4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.739400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.646000E-01
Normal-vs-Stage2
2.196000E-01
Normal-vs-Stage3
3.280400E-02
Normal-vs-Stage4
9.002800E-01
Stage1-vs-Stage2
2.890800E-01
Stage1-vs-Stage3
1.689220E-01
Stage1-vs-Stage4
8.432400E-01
Stage2-vs-Stage3
2.084400E-01
Stage2-vs-Stage4
2.264600E-01
Stage3-vs-Stage4
8.534100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.856600E-01
Normal-vs-AfricanAmerican
3.017400E-01
Normal-vs-Asian
1.806570E-01
Caucasian-vs-AfricanAmerican
9.428000E-01
Caucasian-vs-Asian
4.238200E-01
AfricanAmerican-vs-Asian
6.528000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.102600E-01
Normal-vs-Female
3.685600E-01
Male-vs-Female
3.324400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.341800E-01
Normal-vs-Age(41-60Yrs)
6.847000E-01
Normal-vs-Age(61-80Yrs)
1.347430E-01
Normal-vs-Age(81-100Yrs)
7.597800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.866000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.046010E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.206380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.414500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.187600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.827400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.289200E-01
Normal-vs-Daily Drinker
1.429440E-01
Normal-vs-Weekly Drinker
3.315200E-01
Normal-vs-Occasional Drinker
5.150000E-01
Normal-vs-Social Drinker
7.229000E-01
Non Drinker-vs-Daily Drinker
9.667000E-01
Non Drinker-vs-Weekly Drinker
4.831600E-01
Non Drinker-vs-Occasional Drinker
1.978790E-01
Non Drinker-vs-Social Drinker
1.401590E-01
Daily Drinker-vs-Weekly Drinker
4.159600E-01
Daily Drinker-vs-Occasional Drinker
1.567820E-01
Daily Drinker-vs-Social Drinker
1.146960E-01
Weekly Drinker-vs-Occasional Drinker
6.113000E-01
Weekly Drinker-vs-Social Drinker
4.533600E-01
Occasional Drinker-vs-Social Drinker
7.342200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.203570E-01
Normal-vs-Grade 2
2.140000E-02
Normal-vs-Grade 3
3.440300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.409800E-01
Grade 1-vs-Grade 3
8.799600E-01
Grade 1-vs-Grade 4
1.203570E-01
Grade 2-vs-Grade 3
7.866800E-01
Grade 2-vs-Grade 4
2.140000E-02
Grade 3-vs-Grade 4
3.440300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.621210E-01
Normal-vs-NonDiabetic
3.123600E-01
Diabetic-vs-NonDiabetic
4.527200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.707400E-01
Normal-vs-NoPancreatitis
2.479400E-01
Pancreatitis-vs-NoPancreatitis
3.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.898400E-01
Normal-vs-N1
2.456600E-01
N0-vs-N1
8.567600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.228500E-02
Normal-vs-TP53-NonMutant
4.650800E-01
TP53-Mutant-vs-TP53-NonMutant
8.137900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
